Xuanzhu Pharma

轩竹生物

Xuanzhu Pharma

Biotech/Healthcare

Xuanzhu Pharma is a developer of new molecular entity (NME) innovative drugs, mainly engaged in the research and development of NME drugs. Its research areas mainly include frontier new drug R&D fields such as anti-infection, anti-cardiovascular and metabolic diseases, and anti-tumor.

Latest round: IPO (2025)

Source: ChinaBulls — chinabulls.com

Last updated 2025-10-01